Lanthio Pharma Overview

  • Founded
  • 2011
  • Status
  • Acquired/​Merged
  • Employees
  • 4
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $21.8M
Latest Deal Amount

Lanthio Pharma General Information


Developer of peptides for drug applications. The company is a biopharmaceutical company focused on discovering and developing Lantipeptides, a new class of peptides with drug-like properties. The company spun out of the University of Groningen.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Parent Company
Primary Office
  • PO Box 719
  • 9700 Groningen
  • Netherlands
+31 050 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lanthio Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 07-May-2015 $21.8M 00.000 000.00 Completed Clinical Trials - Phase 2
5. Debt - General 21-May-2014 00.000 00.000 Completed Clinical Trials - Phase 2
4. Early Stage VC (Series A) 27-Nov-2012 00.000 00.000 00.000 Completed Product Development
3. Grant 08-May-2012 00000 Completed Product Development
2. Grant 06-Mar-2012 $238K Completed Product Development
1. Seed Round 01-Jan-2011 Completed Startup
To view Lanthio Pharma’s complete valuation and funding history, request access »

Lanthio Pharma Executive Team (5)

Name Title Board Seat Contact Info
Gert Moll Ph.D Chief Scientific Officer
Michiel Lodder Ph.D Vice President, Business Development
You’re viewing 2 of 5 executive team members. Get the full list »

Lanthio Pharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lanthio Pharma Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioGeneration Ventures Venture Capital Minority 000 0000 000000 0
Hanzepoort Venture Capital Minority 000 0000 000000 0
Inkef Capital Venture Capital Minority 000 0000 000000 0
RUG Holding Venture Capital Minority 000 0000 000000 0
To view Lanthio Pharma’s complete investors history, request access »